The Enterprise Value as of December 2025 (TTM) for Neuren Pharmaceuticals Limited (NEU.AX) is 2.42B

According to Neuren Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.42B. This represents a change of 5.75% compared to the average of 2.29B of the last 4 quarters.

Neuren Pharmaceuticals Limited (NEU.AX) Historical Enterprise Value (quarterly & annually)

How has NEU.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Neuren Pharmaceuticals Limited over the last ten years is 703.78M. The current 2.42B Enterprise Value has changed 34.33% with respect to the historical average. Over the past ten years (40 quarters), NEU.AX's Enterprise Value was at its highest in in the December 2023 quarter at 3.14B. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

Neuren Pharmaceuticals Limited (NEU.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Neuren Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neuren Pharmaceuticals Limited (NEU.AX) Average Enterprise Value

How has NEU.AX Enterprise Value performed in the past?

The current Enterprise Value of Neuren Pharmaceuticals Limited (NEU.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Neuren Pharmaceuticals Limited (NEU.AX) Enterprise Value vs. Peers

How is NEU.AX’s Enterprise Value compared to its peers?

Neuren Pharmaceuticals Limited’s Enterprise Value is less than Mesoblast Limited (2.50B), less than Summerset Group Holdings Limited (4.74B), greater than Clarity Pharmaceuticals Ltd (1.13B), greater than Regis Healthcare Limited (2.09B), greater than Clinuvel Pharmaceuticals Limited (424.53M), greater than Immutep Limited (437.61M), greater than Alterity Therapeutics Limited (58.48M), greater than Botanix Pharmaceuticals Limited (152.81M), greater than EZZ Life Science Holdings Limited (54.70M), greater than PYC Therapeutics Limited (708.28M),

Build a custom stock screener for Neuren Pharmaceuticals Limited (NEU.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuren Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neuren Pharmaceuticals Limited (NEU.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neuren Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.